OBJECTIVE: In the current study, we addressed the question if there is depot-specific expression of cellular inhibitor of apoptosis protein-2 (cIAP2) already in childhood and if the relative expression changes with age in parallel with increasing risk of developing visceral adiposity. SUBJECTS: Paired samples of human omental (OM) and subcutaneous (SC) adipose tissue were obtained from 23 patients (12 children and 11 adults). METHOD: mRNA level of cIAP2 was determined using reverse transcription-polymerase chain reaction (RT-PCR) and protein expression confirmed by Western blotting. Apoptosis indices were determined by terminal deoxynucleotidyl transferasemediated dUTP-fluorescein nick-end labelling (TUNEL). RESULTS: cIAP2 mRNA was 1.51-fold higher in OM compared with SC adipose tissue (OM4SC in 20 of 23 subjects; Po0.001). Western blots were in agreement with mRNA expression (OM4SC in nine of 10 subjects, Po0.01). Subgroup analyses showed depot difference in both children (Po0.01) and adults (Po0.05). Contrary to the hypothesis, depot-specific difference in mRNA expression of cIAP2 was significantly higher in children compared with adults (Po0.05). We were unable to demonstrate any difference in the basal apoptosis rate between adipocytes from the two depots. There was no significant association between cIAP2 mRNA expression and BMI or sex. CONCLUSIONS: The results demonstrated for the first time that depot-specific difference in cIAP2 expression is consistent in children and adults. This suggests that the higher expression of cIAP2 in OM than in SC adipose tissue may be due to inherent properties of cells from the two depots. The more pronounced depot-specific difference in children than in adults may reflect a net gain in visceral adipose tissue during growth.
Introduction
The prevalence of obesity has increased dramatically during the past decades. The increase is not restricted to adults, as the prevalence of overweight and obesity is rapidly increasing also in children, both in developed and developing countries. Obesity is characterized by an increase in adipose tissue mass. Body fat mass, particularly visceral fat accumulation, is closely associated with insulin resistance, cardiovascular disease, hypertension and other serious metabolic disorders. 2 This has highlighted the importance of identifying genetic factors regulating not only fat mass but also fat distribution.
It is known that omental (OM) and subcutaneous (SC) adipocytes differ in various metabolic properties regulating fat cell volume. 3, 4 Replication, differentiation and apoptotic response of human adipose cells appear to be influenced by anatomic region. 5, 6 . Therefore, adipose tissue distribution could results from site-specific difference in the regulation of these processes. Recently, it was shown that regional properties may be related to site-specific differences in expression of genes coding important functional proteins. 7 For example, leptin and PPARg expression are higher in SC than OM adipose tissue. 8, 9 In contrast, expression of the insulin receptor (Ex 11 À ) is higher in OM compared to SC adipose tissue. 9 The cellular inhibitor of apoptosis protein-2 (cIAP2) is a member of the inhibitor of apoptosis protein family (IAPs), which is involved in regulation of apoptosis during cell proliferation and differentiation. [10] [11] [12] The role of IAPs in human adipose tissue is not clear, but a growing line of evidence suggests that it may play a role in regulation of body fat distribution via the modulation of fat cell apoptosis. One report showed that the differentiation-dependent expression of the neuronal apoptosis inhibitory protein (NAIP) in 3T3-L1 adipose cells may correlate with development of resistance of adipocytes to apoptosis. 13 Two other studies reported that cIAP2 mRNA is expressed in depotspecific manner in adult human adipose cells. 14, 15 So far, research on difference in gene expression has focused on adults. Very little is known about site-related gene expression in adipose tissue of children. Since there are age-dependent differences in human adipose tissue with respect to mass and distribution, we addressed the question if there is depot-specific expression of cIAP2 already in childhood and, if so, if the relative expression changes with age in parallel with increasing risk of developing visceral adiposity. In the current study, we have therefore compared the levels of expression of cIAP2 both on the mRNA and protein level in OM and SC adipose tissue of children and adults. In addition, we investigated the relationship between levels of cIAP2 expression and rate of adipocyte apoptosis, body mass index (BMI) and sex.
Methods

Subjects and sample acquisition
Patients subjected to open abdominal elective surgery at Nanjing Children's Hospital, the First Affiliated Hospital of Nanjing Medical University, and Umeå University Hospital were recruited to the study. The experimental protocols were approved by the Ethics Committee, Nanjing Medical University, China and the Ethics Committee, Faculty of Medicine and Odontology, Umeå University, Sweden and all patients involved gave informed consent, either directly or via their parents. Abdominal SC and OM adipose tissue biopsies were obtained from 23 patients (12 children (five girls, seven boys, 3 months-12 y of age) and 11 adults (six women, five men, aged 30-72 y of age)). Of the children, six had surgery due to Hirschsprung's disease, two underwent appendectomy and four reconstructive surgeries due to malformation of the digestive tract. Of the adults, five had surgery for nonmalignant gynaecological disease; six underwent abdominal elective surgery due to benign tumours of the digestive system. None of the individuals had diabetes, a family history of diabetes or suffered from severe systemic illnesses. The adults had been weight stable prior to the operation. BMI ranged from 13.6-29.9 kg/m 2 (children:
13.6-21.2 kg/m 2 and adults: 18.0-29.9 kg/m 2 ). All patients had been fasted for at least 8 h prior to the surgery and underwent general anaesthesia. All visible blood vessels were immediately removed from collected adipose tissue. Part of each biopsy was immediately frozen in liquid nitrogen and stored at À701C until analysis. The rest was fixed by 10% neutral formalin and embedded in paraffin for evaluation of apoptosis.
RNA preparation and RT-PCR
The mRNA levels of cIAP2 were determined in all subjects from whom total RNA was available from both SC and OM adipose tissue. Total RNA was prepared using the TRIzol Reagent (Invitrogen life technologies, CA, USA), according to the manufacturer's protocol. RNA was quantified spectrophotometrically. The integrity of the RNA was verified by ethidium bromide staining of ribosomal RNA bands using 1% agarose gel. The RNA obtained was stored at À701C until use.
RT-PCR was performed to analyse cIAP2 mRNA. Total RNA (0.5B1 mg) was reverse transcribed for 1 h at 421C in 20 ml buffer, containing 200 U MMLV reverse transcriptase, 0.5 mg Oligo d (T) 16 , 0.5 mmol/l dNTP, 20 U RNase-inhibitor. Complementary DNA (cDNA) samples were denatured for 5 min at 951C, and 5 ml cDNA from each sample was used for subsequent PCR amplification in a final volume of 50 ml buffer containing 2.5 U Taq DNA polymerase, 0.2 mmol/l dNTP, 2.5 mmol/l MgCl 2 and 0.4 mmol/l of each primer. PCR conditions were 951C for 5 min followed by 30 cycles at 941C for 30 s, 601C for 45 s and 721C for 1 min, and, finally extending 721C for another 10 min. The reagents for RT were supplied by Promega Corp. (Madison, USA). The reagents for PCR were from Roche (Mannheim, Germany). In this semiquantitative RT-PCR, two primer sets were used simultaneously (Table 1) . To ensure that the amplification of both cIAP2 and b-actin cDNA were within the exponential range, different numbers of PCR cycles were used. The primers for bactin were added at the sixth cycle of each PCR amplification.
After amplification, 10 ml of the mixture was separated on 1.5% agarose gel stained with ethidium bromide. The gels were visualized under UV light, the density as well as the ratio of cIAP2 to b-actin were measured and analysed using the Quantitation software, Version 4 Windows and Macintosh (Bio-Rad Laboratories, Hercules, CA, USA).
Protein isolation and Western blot analysis Expression of the cIAP2 protein level was analysed in 10 paired samples (six children and four adults). Specimens of SC and OM tissue frozen in liquid nitrogen and stored at À701C were used. Pieces ranging from 100 to 300 mg were crushed and lysed in protein lysis buffer (RIPA) with protease inhibitors (100 mg/ml PMSF, 60 mg/ml aprotinin; 1 mM sodium orthovanadate), and homogenized with sonic cell disruptor B-30 (Branson sonic Power Co., Switzerland). The homogenate was centrifuged at 14 000 rpm for 30 min and 
Results
Paired comparisons of mRNA expression of cIAP2 from SC and OM adipose tissue were quantified by RT-PCR, as shown in Figure 1a . There was a striking variation in expression level between individuals, particularly in OM (Figure 1b ). Despite this, there was a significant depot-specific difference Expression of cIAP2 in human subcutaneous and omental adipose tissue X Li et al in cIAP2 mRNA expression level (Table 2 ). cIAP2 mRNA was 1.51-fold higher in OM compared with SC adipose tissue (OM4SC in 20 of 23 subjects; Po0.001). A subgroup analyses showed that the depot difference was present in both children (Po0.01) and adults (Po0.05). Moreover, depot-specific difference in mRNA expression of cIAP-2 was significantly higher in children compared to adults (Po0.05). Western blots are shown in Figure 2 . In agreement with the mRNA expression, the cIAP2 protein level was higher in OM compared to SC (OM4SC in nine of 10 subjects, Po0.01).
Immunohistochemistry analysis indicated no difference between SC and OM in apoptotic indices of adipocytes (apoptotic indices o 1%). mRNA levels of cIAP2 did not correlate to age, BMI and sex with expression of either OM or SC.
Discussion
In the present study, the expression levels of cIAP2 mRNA in OM and SC adipose tissue were compared by semiquantitative RT-PCR both in children and adults. The average expression level was significantly higher in OM than in SC adipose tissue. This is in accord with Montague et al, 14 who demonstrated a higher mRNA expression of cIAP2 in OM than SC adipocytes from adults. The same authors also showed that cIAP2 mRNA expression is higher in human preadipocytes from OM than that from SC fat. 15 However, their study focused only on mRNA levels. As mRNA expression does not always reflect protein expression or the concentration of the fully processed protein, we extended the observation by certifying that the principal difference between OM and SC adipose tissue occurs also on the protein level.
The cIAP2 was originally identified as a protein, which associates with the TNFa receptor-signalling complex, suggesting that it may be involved in regulation of TNFa signalling. 16 Overexpression of human cIAP2 protein can suppress cell death induced by a variety of stimuli. When compared with human isolated adipocytes, preadipocytes cultured in serum containing medium have higher cIAP2 mRNA levels and also lower sensitivity to TNFa-induced apoptosis. 14, 15, 17 Therefore, the expression of cIAP2 in SC and OM adipose tissue may reflect depot-specific susceptibility to apoptosis, and thereby adipose tissue loss or deposition.
The growth and distribution of human adipose tissue is markedly age and sex dependent. Site-specific adipose cell accumulation in early life may contribute to depot-specific fat stores in later life. Many observations suggest that obesity is programmed during critical periods of development, for example adiposity in early infancy tracks poorly into adulthood, while adiposity in adolescence appears to increase the risk of persistent obesity and its complications. 18, 19 In the present study, we compared cIAP2 expression pattern in children with that of adults. The results showed that the depot-specific difference in mRNA expression of cIAP2 was consistent in children and adults. cIAP2 mRNA expression did not exhibit marked age-dependent changes. Nor were there significant associations between cIAP2 mRNA expression and BMI or sex. Interestingly, the depot-specific difference between OM and SC was more pronounced in children. Since visceral adipose tissue is limited in childhood, the generally higher expression in children may merely reflect net gain in visceral adipose tissue during growth, and therefore lower sensitivity to apoptosis. This possibility is supported by the observation that NIAP expression levels in subcutaneous abdominal preadipocytes is 3-5-fold higher following weight loss, which favours weight regain. 20 In this study, we were unable to demonstrate any difference in the basal apoptosis rate between adipocytes from the two depots. A likely explanation is that the basal apoptotic indices were too low for precise quantification and comparison. This view is supported by the fact that Prins et al 17 showed that the basal apoptotic index of adipose cells cultured in serum-containing medium was very low, independent of method used. 6 However, we cannot rule out that the method used is too insensitive to demonstrate a difference in apoptosis indices between the two sites of adipose tissue, which could correlate to the difference in cIAP2 expression. Furthermore, the physiological role of siterelated expression difference in cIAP2 in adipose tissue remains to be explored. Expression of cIAP2 in human subcutaneous and omental adipose tissue X Li et al
In summary, we have compared the expression of cIAP2 mRNA in SC and OM adipose tissue in 12 children and 11 adults. A higher relative expression in OM as compared to SC adipose tissue was found in children and adults. This suggests that the different expression of cIAP2 between depots may be due to inherent properties of cells from the two depots. The more pronounced depot-specific difference in children might reflect a net gain in visceral adipose tissue during growth.
